Novel Macrocyclic Antagonists of the Calcitonin Gene-Related Peptide Receptor: Design, Realization, and Structural Characterization of Protein-Ligand Complexes.
Cansfield, A.D., Ator, M.A., Banerjee, J., Bestwick, M., Bortolato, A., Brown, G.A., Brown, J., Butkovic, K., Cansfield, J.E., Christopher, J.A., Congreve, M., Cseke, G., Deflorian, F., Dugan, B., Hunjadi, M.P., Hutinec, A., Inturi, T.K., Landek, G., Mason, J., O'Brien, A., Ott, G.R., Rupcic, R., Saxty, G., Southall, S.M., Zadravec, R., Watson, S.P.(2022) ACS Chem Neurosci 13: 751-765
- PubMed: 35245037 
- DOI: https://doi.org/10.1021/acschemneuro.1c00696
- Primary Citation of Related Structures:  
7P0F, 7P0I - PubMed Abstract: 
A series of macrocyclic calcitonin gene-related peptide (CGRP) receptor antagonists identified using structure-based design principles, exemplified by HTL0028016 ( 1 ) and HTL0028125 ( 2 ), is described. Structural characterization by X-ray crystallography of the interaction of two of the macrocycle antagonists with the CGRP receptor ectodomain is described, along with structure-activity relationships associated with point changes to the macrocyclic antagonists. The identification of non-peptidic/natural product-derived, macrocyclic ligands for a G protein coupled receptor (GPCR) is noteworthy.
Organizational Affiliation: 
Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K.